Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study (Q85217276)
Jump to navigation
Jump to search
scientific article published on 18 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study |
scientific article published on 18 October 2010 |
Statements
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study (English)
Anne Etienne
Raynier Devillier
Emilie Romeo
Aude Charbonnier
Evelyne D'incan
Benjamin Esterni
Christine Arnoulet
18 October 2010